2010
DOI: 10.1016/j.exphem.2010.01.004
|View full text |Cite|
|
Sign up to set email alerts
|

Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation

Abstract: Objective Angiotensin II (Ang II), a potent vasoconstrictor, affects the growth and development of hematopoietic cells. Mixed findings have been reported for the effects of ACE inhibitors on radiation-induced injury to the hematopoietic system. We investigated the consequences of different regimens of the ACE inhibitor captopril on radiation-induced hematopoietic injury. Methods C57BL/6 mice were either sham irradiated or were exposed to 60Co total body irradiation (0.6 Gy/min). Captopril was provided in the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
88
2

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(93 citation statements)
references
References 41 publications
3
88
2
Order By: Relevance
“…In normal mice, ACE inhibition shows a biphasic modulation of bone marrow progenitor proliferation. Short-term ACE inhibition (2 days) suppressed the G0 to G1 transition of Lin 2 cells (i.e., bone marrow progenitor cells) (Davis et al, 2010). This effect of short-term ACE inhibition reduces the potential shortterm injury to stem cells, and is what was seen in the irradiation experiments described earlier that resulted in enhanced stem-cell survival (Charrier et al, 2004).…”
Section: Sca1mentioning
confidence: 54%
See 1 more Smart Citation
“…In normal mice, ACE inhibition shows a biphasic modulation of bone marrow progenitor proliferation. Short-term ACE inhibition (2 days) suppressed the G0 to G1 transition of Lin 2 cells (i.e., bone marrow progenitor cells) (Davis et al, 2010). This effect of short-term ACE inhibition reduces the potential shortterm injury to stem cells, and is what was seen in the irradiation experiments described earlier that resulted in enhanced stem-cell survival (Charrier et al, 2004).…”
Section: Sca1mentioning
confidence: 54%
“…This effect of short-term ACE inhibition reduces the potential shortterm injury to stem cells, and is what was seen in the irradiation experiments described earlier that resulted in enhanced stem-cell survival (Charrier et al, 2004). In contrast, longer-term treatment with ACE inhibitors (greater than 7 days) appeared to increase the proliferation of bone marrow progenitors (Davis et al, 2010). The paradoxical effects between acute versus chronic ACE inhibition imply that ACE regulates hematopoiesis through multiple peptides and/or pathways.…”
Section: Sca1mentioning
confidence: 69%
“…Short-term ACE inhibition (2 days) suppressed the G 0 to G 1 transition. 77 This effect of short-term ACE inhibition is what was seen in the irradiation experiments described above that resulted in enhanced survival of stem cells. 76 In contrast, longer-term treatment with ACE inhibitors (greater than 7 days) appears to increase proliferative progenitors compared to untreated control mice.…”
Section: Discussionmentioning
confidence: 67%
“…76 In contrast, longer-term treatment with ACE inhibitors (greater than 7 days) appears to increase proliferative progenitors compared to untreated control mice. 77 The paradoxical effects between acute vs. chronic ACE activity deprivation implies that ACE regulates hematopoiesis through multiple peptides or pathways. Further complicating the story is examination of HSC populations in ACE-KO that ACE + CD34 +/-CD45 -are the markers for hemangioblast because such cells produced progenitors for both endothelium and lympho-hematopoietic stem cells.…”
Section: Discussionmentioning
confidence: 99%
“…Hematopoietic progenitor cell colony-forming assay was investigated as described previously (Davis et al 2010). Three mice in each group were sacrificed at the seventh day after irradiation and bone marrow from femur were collected and mixed.…”
Section: Hematopoietic Progenitor Cell Colony-forming Assaymentioning
confidence: 99%